Intersect ENT Announces Positive Preliminary Clinical Results for the PROPEL Mini Steroid Releasing Implant in Patients with Frontal Sinus Disease Menlo Park, Calif. – August 17, 2015 – Intersect ENT, Inc. (Nasdaq:XE - Medicine Park - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-08-17 10:01:39 Medicine Medical equipment Medical technology Propel mometasone furoate implant Sinus implant Intersect ENT Sinusitis Sinus Otorhinolaryngology Paranasal sinuses Frontal sinus Ethmoid sinus		Intersect ENT Announces Positive Preliminary Clinical Results for the PROPEL Mini Steroid Releasing Implant in Patients with Frontal Sinus Disease Menlo Park, Calif. – August 17, 2015 – Intersect ENT, Inc. (Nasdaq:XE Add to Reading List Source URL: propelopens.com Download Document from Source Website File Size: 27,50 KB Share Document on Facebook

	What you need to know about… The paranasal sinuses are a group of air-filled cavities located in the facial area. The maxillary sinuses are located under DocID: 1ur9X - View Document
	Intersect ENT Announces FDA Approval of Additional Indication for PROPEL® Mini Sinus Implant PROPEL Mini Now Indicated to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—March 23, 2016—Intersect ENT, In DocID: 1mCRC - View Document
	Intersect ENT Announces Positive Preliminary Clinical Results for the PROPEL Mini Steroid Releasing Implant in Patients with Frontal Sinus Disease Menlo Park, Calif. – August 17, 2015 – Intersect ENT, Inc. (Nasdaq:XE DocID: 1lN0M - View Document
	Intersect ENT Announces FDA Submission to Seek Expanded Indication of PROPEL Mini Steroid Releasing Implant to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—September 29, 2015—Intersect ENT, Inc. (Nasd DocID: 1l9KI - View Document
	Intersect ENT Announces Positive Clinical Results from Three Studies Evaluating Steroid Releasing Implants Placed in the Physician’s Office Menlo Park, Calif. and Dallas, Texas – September 28, 2015 – Intersect ENT, DocID: 1kvXr - View Document